Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Autophagy
    (1)
  • Endogenous Metabolite
    (1)
  • FAAH
    (3)
  • GluR
    (3)
  • Glucagon Receptor
    (3)
  • Lipase
    (16)
  • Lipid
    (1)
  • MAGL
    (8)
  • Others
    (17)
Filter
Search Result
Results for "

magl

" in TargetMol Product Catalog
  • Inhibitor Products
    46
    TargetMol | Activity
  • Natural Products
    3
    TargetMol | inventory
  • Peptides Products
    2
    TargetMol | natural
  • Recombinant Protein
    2
    TargetMol | composition
  • Isotope products
    1
    TargetMol | Activity
MAGL-IN-9
T81878
MAGL-IN-9, also referred to as compound 16, is a reversible inhibitor of monoacylglycerol lipase (MAGL) with a potent IC50 value of 2.7 nM [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
MAGL-IN-10
T81881
MAGL-IN-10, a reversible monoacylglycerol lipase (MAGL) inhibitor, exhibits favorable ADME properties and low in vivo toxicity. It is applicable in the study of cancer, neurological disorders, and inflammatory pathologies [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
MAGL-IN-11
T81880
MAGL-IN-11 (compound 29) is a selective, reversible inhibitor of monoacylglycerol lipase (MAGL), with potential in researching inflammation, cancer, and antioxidants [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
MAGL-IN-8
T81879
MAGL-IN-8 (compound 13) serves as a reversible inhibitor of monoacylglycerol lipase (MAGL), exhibiting an inhibitory concentration half-maximal (IC50) value of 2.5 ± 0.4 nM for human MAGL (hMAGL) [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
FAAH/MAGL-IN-3
T62671
FAAH/MAGL-IN-3 (Compound 10) is an irreversible dual inhibitor of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) that acts on FAAH (IC50: 179 nM) and MAGL (IC50: 759 nM). FAAH/MAGL-IN-3 showed little PAMPA (parallel artificial membrane permeability assay) permeability.
  • $1,520
10-14 weeks
Size
QTY
MAGL-IN-5
T9967359714-55-9
MAGL-IN-5 is a non-selective lipase inhibitor.
  • $39
In Stock
Size
QTY
MAGL-IN-4
T96872135785-20-3
MAGL-IN-4 (His121 ARG57) is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases.
  • $159
In Stock
Size
QTY
TargetMol | Inhibitor Sale
FAAH/MAGL-IN-2
T617072765077-82-3
FAAH/MAGL-IN-2, a potent and reversible inhibitor of FAAH and MAGL, demonstrates oral activity and the ability to cross the blood-brain barrier. It exhibits IC50 values of 11 nM for FAAH and 36 nM for MAGL (Ki values of 28 nM and 60 nM, respectively). This compound shows promise for neuropathic pain research, without impairing locomotion [1].
  • $1,520
10-14 weeks
Size
QTY
MAGL-IN-1
T119392324160-91-8
MAGL-IN-1 is a selective and potent monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 80 nM.
  • $34
5 days
Size
QTY
MAGL-IN-6
T624892414320-29-7
MAGL-IN-6 is a potent inhibitor of MAGL (IC50: 4.71 nM). MAGL-IN-6 can be used to study neurological diseases.
  • $2,140
8-10 weeks
Size
QTY
FAAH/MAGL-IN-1
T61198
FAAH/MAGL-IN-1, also known as compound SIH 3, is a highly effective inhibitor of FAAH (fatty acid amide hydrolase) and MAGL (monoacylglycerol lipase). It exhibits IC50 values of 31 nM and 29 nM against FAAH and MAGL, respectively. This compound shows promising potential for advancing research in the field of neuropathic pain [1].
  • $1,520
10-14 weeks
Size
QTY
Semaglutide
T19850910463-68-2
Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).
  • $213
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Semaglutide Acetate
T19850L1997361-85-9
Semaglutide Acetate is an agonist of a glucagon-like peptide 1 (GLP-1) receptor and can be used in studies about the treatment of type 2 diabetes.
  • $239
In Stock
Size
QTY
ABX-1431
T53531446817-84-0
ABX-1431 (Elcubragistat) is a selective and orally available CNS-penetrant monoacylglycerol lipase (MAGL MGLL) inhibitor (IC50: 14 nM).
  • $30
In Stock
Size
QTY
Maglifloenone
TN540982427-77-8
Maglifloenone is a natural product of Magnolia, Magnoliaceae. The catalog number is TN5409 and the CAS number is 82427-77-8. Maglifloenone can be used as a reference standard.
  • $508
Backorder
Size
QTY
TargetMol | Inhibitor Sale
Vamagloxistat
T808792408241-62-1
Vamagloxistat is a glycolate oxidase inhibitor utilized to mitigate hyperoxaluria and reduce the formation of kidney stones [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Pomaglumetad methionil anhydrous
T11907635318-55-7
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.
  • $1,474
Backorder
Size
QTY
TargetMol | Inhibitor Sale
Rehmaglutin D
TN4904103744-84-9
Rehmaglutin D is a natural product of Ailanthus, Simaroubaceae. The catalog number is TN4904 and the CAS number is 103744-84-9. Rehmaglutin D can be used as a reference standard.
  • $250
Backorder
Size
QTY
TargetMol | Inhibitor Sale
JJKK 048
T156141515855-97-6In house
JJKK 048 is a potent and selective MAGL inhibitor.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MAGLi 432
T629372361575-20-2
MAGLi 432 is a potent, highly selective, non-covalent, reversible (MAGL) inhibitor that binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme), MAGLi 432 can be used to study neurological disorders such as chronic inflammation, multiple sclerosis, blood-brain barrier dysfunction, Alzheimer's disease and Parkinson's disease.
  • $2,140
6-8 weeks
Size
QTY
Semaglutide TFA (910463-68-2 free base)
T12878
Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment.
  • $232
Backorder
Size
QTY
Semaglutide-d8 Tetratrifluoroacetate
TMIJ-0258
Semaglutide-d8 Tetratrifluoroacetate is a deuterated compound of Semaglutide Tetratrifluoroacetate.
  • Inquiry Price
20 days
Size
QTY
Pomaglumetad methionil
T12520956385-05-0
Pomaglumetad methionil is an oral methionine prodrug of the potent specific agonist of mGlu2/3 receptor LY404039.
  • $3,020
10-14 weeks
Size
QTY
Pomaglumetad methionil hydrochloride
T61972635318-26-2
Pomaglumetad methionine hydrochloride (LY2140023 hydrochloride) is a methionine prodrug of LY404039 with oral activity. LY404039 is a selective mGlu2 3 receptor agonist. Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) has research value in schizophrenia.
  • $212
In Stock
Size
QTY
Pemaglitazar
T69191496050-39-6
Pemaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist, with hypoglycemic activity.
  • $1,520
6-8 weeks
Size
QTY
JW 642
T156321416133-89-5
JW 642 is an effective inhibitor of monoacylglycerol lipase (MAGL) (IC50: 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively).
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
N-Arachidonyl Maleimide
T21905876305-42-9
N-Arachidonyl maleimide is a potent, irreversible monoacylglycerol lipase (MAGL) inhibitor with an IC 50 value of 140 nM [1].
  • $53
5 days
Size
QTY
OMDM169
T28235130193-44-1
OMDM169 is a potent and selective MAGL inhibitor. OMDM169 could enhances 2-AG levels and of exerts analgesic activity via indirect activation of cannabinoid receptors. OMDM169 exhibited 0.13 microM
  • $2,720
10-14 weeks
Size
QTY
AA38-3
T937465815-76-1
AA38-3 (1-Piperidinecarboxylic acid, 4-nitrophenyl ester) inhibites three SHs (ABHD6, ABHD11, and FAAH)
  • $39
In Stock
Size
QTY
SA57
T128261346169-63-8
SA57 is a potent, selective inhibitor of FAAH(IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH).
  • $78
35 days
Size
QTY
JZP-MA-13
T73317
JZP-MA-13 is a selective α/β-hydrolase domain 6 (ABHD6) inhibitor, demonstrating impressive specificity with an IC50 value of 392 nM, and exhibits no inhibitory effects on monoacylglycerol lipase (MAGL), ABHD12, fatty acid amide hydrolase (FAAH), or other serine hydrolases. Additionally, JZP-MA-13 serves as a positron emission tomography (PET) ligand for in vivo imaging of ABHD6.
  • $1,520
6-8 weeks
Size
QTY
SAR127303
T247581352011-38-1
SAR127303 is an effective covalent inhibitor of MAGL. SAR127303 behaves as a selective and competitive inhibitor of mouse and human MAGL.
  • $1,520
6-8 weeks
Size
QTY
JZP-430
T156351672691-74-5
JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM). It also shows ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL).
  • $101
In Stock
Size
QTY
CAY10762
T364982514-37-6
CAY10762 is an inhibitor of monoacylglycerol lipase (MAGL; IC50= 34.1 nM).1It reduces hydrogen peroxide-induced lactate dehydrogenase (LDH) release from Neuro2a cells when used at a concentration of 1 μM. CAY10762 (10 mg/kg) increases levels of 2-arachidonoyl glycerol in mouse brain. 1.Castelli, R., Scalvini, L., Vacondio, F., et al.Benzisothiazolinone derivatives as potent allosteric monoacylglycerol lipase inhibitors that functionally mimic sulfenylation of regulatory cysteinesJ. Med. Chem.63(3)1261-1280(2020)
  • $95
35 days
Size
QTY
KML29
T40521380424-42-9
KML29 is highly selective and effective monoacylglycerol lipase (MAGL) inhibitor. It has effective inhibition of human/mouse/rat MAGL (IC50: 5.9/15/43 nM). It has not inhibitory for FAAH (IC50 > 50 μM). It also effectively and selectively blocks hydrolysis of 2-arachidonoylglycerol (2-AG) in mice (IC50: 2.5 nM, 2-AG; >50 μM, AEA).
  • $40
In Stock
Size
QTY
MJN110
T58151438416-21-7
MJN110 (Cravatt Reagent) is a potent and selective MAGL inhibitor. Cravatt Reagent inhibits MAGL (IC50 = 9.1 nM). MJN110(Cravatt Reagent) Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
  • $43
In Stock
Size
QTY
JNJ-42226314
T117241252765-13-1
JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.JNJ-42226314 shows efficacy via endogenous cannabinoid-2-acryloylglycerol (2-AG) in models of neuropathic pain and inflammatory pain.
  • $48
In Stock
Size
QTY
URB754
T3737486672-58-4
URB754 is a potent and noncompetitive inhibitor of monoacylglycerol lipase (MAGL), exhibiting an IC50 value of 200 nM for the recombinant rat brain enzyme. However, it does not inhibit human recombinant, rat brain, or mouse brain MAGL at concentrations up to 100 μM. There is evidence that the MAGL inhibitory activity of URB754 may be attributed to the impurity bis(methylthio)mercurane (IC50 = 11.9 nM for rat recombinant MAGL) that is found in commercial preparations. URB754 inhibits rat brain fatty acyl amide hydrolase (FAAH) with an IC50 value of 32 μM and binds weakly to the rat central cannabinoid (CB1) receptor with an IC50 value of 3.8 μM. It does not inhibit COX-1 or COX-2 at concentrations up to 100 μM. Inhibition of MAGL hydrolysis of 2-arachidonoyl glycerol (2-AG) is associated with enhanced stress-induced analgesia and may represent a novel drug target in pain and stress management.
  • $88
35 days
Size
QTY
JZL195
T23381210004-12-8
JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor.
  • $39
In Stock
Size
QTY
PF-06795071
T164962075629-81-9
PF-06795071 is an effective and selective covalent inhibitor of MAGL (IC50: 3 nM).
  • $2,420
10-14 weeks
Size
QTY
ML-211
T89742205032-89-7
ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50 = 17 nM) and the related LYPLA2 (IC50 = 30 nM)
  • $123
In Stock
Size
QTY
JZL 184
T65541101854-58-3
JZL 184 is a potent and selective inhibitor of MAGL with IC50 of 8 nM and 4 μM for inhibition of MAGL and FAAH in mouse brain membranes respectively.
  • $34
In Stock
Size
QTY
ML-​226
T89942055172-43-3
ML226 is a α/β hydrolase domain-containing protein 11 (ABHD11) inhibitor that inhibits ABHD11 in vitro and in situ.
  • $218
In Stock
Size
QTY
JZP-361
T277031680193-80-9
JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6. JZP-361 displays anti-histaminergic activities. JZP-361 can be used in studies about asthma.
  • $64
In Stock
Size
QTY
WWL70
T17260947669-91-2
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM).
  • $41
In Stock
Size
QTY
euphol
T5737514-47-6
Euphol, an alcohol tetracyclic triterpene, has a wide range of pharmacological properties and is considered to have anti-inflammatory action.
  • $84
In Stock
Size
QTY